12885_2021_8836_MOESM2_ESM.tif (7.35 MB)
Additional file 2 of Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
figure
posted on 2021-10-09, 03:19 authored by F. Weiner, J. T. Schille, D. Koczan, X.-F. Wu, M. Beller, C. Junghanss, M. Hewicker-Trautwein, H. Murua Escobar, I. NolteAdditional file 2: Supplementary Fig. 1 Immunocytochemistry staining of control cells and cells after exposure to 5 μM FX-9 for 12 h.
